PURE Bioscience, Inc. announced the resignation of Peter C. Wulff as its Chief Financial Officer and Chief Operating Officer. Wulff informed the Company that he has accepted a new assignment as CFO for a venture-backed medical device company. With Wulff's departure, Mark Elliott, PURE's Controller, has been promoted and will play a new leadership role in PURE's Finance department as the Company's Vice President, Finance and will serve as the Company's principal financial and accounting officer.

Elliott joined PURE in 2004 and has been responsible for managing all accounting and regulatory reporting activities since May 2006. He has also been responsible for establishing all current financial and reporting systems. Prior to joining PURE, Elliott worked in government accounting.